🔎 Trials Near Me

Akèy › Lukemi lenfositè kwonik › Washington › Spokane

Etid klinik pou Lukemi lenfositè kwonik nan Spokane, WA

6 etid pou Lukemi lenfositè kwonik ap chèche patisipan nan sit nan ak bò kote Spokane (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Cancer Care Northwest - Spokane South, Spokane
  • Cancer Care Northwest-Valley, Spokane
  • Cancer Care Northwest-North Spokane, Spokane
Laj 40 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT05334069

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)

Ap rekriteFaz 3
  • Medical Oncology Associates, PS (dba Summit Cancer Centers) ( Site 0010), Spokane
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT06136559

A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

Ap rekriteFaz 3
  • Medical Oncology Associates, PS, Spokane
Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT05254743

ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL

Ap rekriteFaz 3
  • Medical Oncology Associates - Spokane, Spokane
Laj 18 ak plis · Tout sèks · Mizajou Aug 11, 2026 · NCT07342478

Etid Lukemi lenfositè kwonik nan lòt vil

Lòt etid nan Spokane

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.